Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virus-Specific Impact of Respiratory Viruses on Adult Emergency Department Outcomes.

Journal of medical virology·2026
Same author

Innovation in sepsis trials: rethinking endpoints, statistics and patient stratification.

Intensive care medicine experimental·2026
Same author

Effect of Weight-based versus Absolute Norepinephrine Dosing on Mortality Risk in Obese Patients with Septic Shock: An Observational, Multicohort, Retrospective Study.

Anesthesiology·2026
Same author

Evaluating implementation of nurse-led community-based ultrasound screening for developmental dysplasia of the hip in Japan: A mixed-methods RE-AIM study.

International journal of nursing studies·2026
Same author

Nurses' Challenges in Performing Ultrasound Hip-Screening Techniques for Home Visits to Newborns and Infants: A Descriptive Case Study.

Journal of nursing management·2026
Same author

[The latest SOFA score update: a balancing act between ambition and reality].

Die Anaesthesiologie·2026

Related Experiment Video

Updated: Jun 10, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

TLR-based immune adjuvants.

Folkert Steinhagen1, Takeshi Kinjo, Christian Bode

  • 1Cancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, United States.

Vaccine
|August 18, 2010
PubMed
Summary
This summary is machine-generated.

This study examines Toll-like receptor (TLR) ligands as vaccine adjuvants, detailing their immune response and clinical efficacy. The research reviews TLR ligands and their safety profiles, focusing on available clinical data for adjuvant potential.

More Related Videos

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Related Experiment Videos

Last Updated: Jun 10, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Toll-like receptors (TLRs) are key components of the innate immune system.
  • TLR ligands can modulate immune responses, making them potential vaccine adjuvants.

Purpose of the Study:

  • To describe the immune response induced by various Toll-like receptor ligands.
  • To evaluate the efficacy and safety of TLR ligands as vaccine adjuvants.

Main Methods:

  • Review of literature on TLR ligands and their ability to trigger individual TLRs.
  • Analysis of clinical data for TLR ligands with available efficacy and safety results.

Main Results:

  • Certain TLR ligands effectively induce immune responses suitable for vaccine adjuvants.
  • Clinical data indicates varying efficacy and safety profiles among different TLR ligands.

Conclusions:

  • TLR ligands represent a promising class of vaccine adjuvants.
  • Careful selection and evaluation of TLR ligands are crucial for developing safe and effective vaccines.